Harvard Medical School

Medications

Repurposing a familiar drug for COVID-19

For the past year and a half, the COVID-19 pandemic has continued to engulf the globe, fueled in part by novel variants and the uneven distribution of vaccines. Every day, hundreds of thousands of new COVID-19 cases and thousands ...

Diseases, Conditions, Syndromes

Deficient immune cells implicated in TB disease progression

Nearly a quarter of the world's population is estimated to be infected with Mycobacterium tuberculosis (M.tb), the pathogen that causes tuberculosis, but less than 15 percent of infected individuals develop the disease.

page 9 from 40